Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Imacis-1

Known as: Imacis 1 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
We evaluated the intravenous infusion of a cocktail of I-131 anti-CEA and anti-C A19-9 monoclonal antibody F(ab’)2 (IMACIS-1) in… Expand
Is this relevant?
1993
1993
IMACIS-1 is a radiopharmaceutical containing a mixture of Iodine-131 labeled monoclonal antibodies to CEA and CA19-9. IMACIS-1… Expand
Is this relevant?
1990
1990
Most of the diagnostic methods currently used for the detection of neoplastic masses provide indirect evidence. To obtain greater… Expand
Is this relevant?
1990
1990
The clinical trials of immunoscintigraphy with a cocktail of 131I anti CEA monoclonal antibody F(ab')2 and 131I anti CA 19-9… Expand
Is this relevant?
1990
1990
The sensitivity of immunoscintigraphy (ISC) with monoclonal antibodies (Mab) depends on the Mab type, the radiophysical… Expand
Is this relevant?
1990
1990
A study was made on 2 types of 131I-labeled anti-CA 19-9 and anti-CEA mouse monoclonal antibodies (IMACIS-1) against human cancer… Expand
Is this relevant?
1989
1989
The clinical usefulness of a I-131 anti CEA F(ab')2 MoAB and CA 19-9 F(ab')2 MoAB cocktail(IMACIS-1) for the localization of a… Expand
Is this relevant?
1989
1989
To determine if IMACIS-1 might have the capability of specifically pinpointing an adenocarcinoma in the human lung, xenografts of… Expand
Is this relevant?